Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2011

Open Access 01-12-2011 | Original investigation

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis

Authors: Henrik Reinhard, Niels Wiinberg, Peter R Hansen, Andreas Kjær, Claus L Petersen, Kaj Winther, Hans-Henrik Parving, Peter Rossing, Peter K Jacobsen

Published in: Cardiovascular Diabetology | Issue 1/2011

Login to get access

Abstract

Intensive multifactorial treatment aimed at cardiovascular (CV) risk factor reduction in type 2 diabetic patients with microalbuminuria can diminish fatal and non-fatal CV. Plasma N-terminal (NT)-proBNP predicts CV mortality in diabetic patients but the utility of P-NT-proBNP in screening for atherosclerosis is unclear. We examined the interrelationship between P-NT-proBNP, presence of atherosclerosis and/or vascular dysfunction in the coronary, carotid and peripheral arteries in asymptomatic type 2 diabetic patients with microalbuminuria that received intensive multifactorial treatment.

Methods and Results

P-NT-proBNP was measured in 200 asymptomatic type 2 patients without known cardiac disease that received intensive multifactorial treatment for CV risk reduction. Patients were examined for coronary, carotid and peripheral atherosclerosis, as defined by coronary calcium score ≥400, carotid intima-media thickness (CIMT) > 0.90 mm, ankle-brachial index < 0.90, and/or toe-brachial index < 0.64, respectively. Carotid artery compliance was also determined and the reactive hyperaemia index (RHI) measured by peripheral artery tonometry was used as a surrogate for endothelial function.
P-NT-proBNP was associated with atherosclerosis in the unadjusted analysis, but not after adjustment for conventional risk factors. P-NT-proBNP was not associated with vascular dysfunction. The prevalence of atherosclerosis in the coronary, carotid and peripheral arteries was 35%, 10% and 21% of all patients, respectively. In total 49% had atherosclerosis in one territory and 15.6% and 1.0% in two and three territories. Low RHI was an independent predictor of coronary atherosclerosis (odds ratio [CI], 2.60 [1.15-5.88] and systolic blood pressure was the only independent determinant of CIMT (0.02 mm increase in CIMT per 10 mmHg increase in systolic blood pressure [p = 0.003]).

Conclusions

Half of asymptomatic patients with type 2 diabetes mellitus and microalbuminuria had significant atherosclerosis in at least one vascular territory despite receiving intensive multifactorial treatment for CV risk reduction. Coronary atherosclerosis was most prevalent, whereas carotid disease was more rarely observed. RHI but not plasma NT-proBNP was predictive of coronary atherosclerosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gaede P, Lund-Andersen H, Parving HH, et al: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008, 358 (6): 580-91. 10.1056/NEJMoa0706245.CrossRefPubMed Gaede P, Lund-Andersen H, Parving HH, et al: Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008, 358 (6): 580-91. 10.1056/NEJMoa0706245.CrossRefPubMed
2.
go back to reference Doust JA, Pietrzak E, Dobson A, et al: How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. Br Med J. 2005, 330 (7492): 625-10.1136/bmj.330.7492.625.CrossRef Doust JA, Pietrzak E, Dobson A, et al: How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. Br Med J. 2005, 330 (7492): 625-10.1136/bmj.330.7492.625.CrossRef
3.
go back to reference Wang TJ, Larson MG, Levy D, et al: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004, 350 (7): 655-63. 10.1056/NEJMoa031994.CrossRefPubMed Wang TJ, Larson MG, Levy D, et al: Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004, 350 (7): 655-63. 10.1056/NEJMoa031994.CrossRefPubMed
4.
go back to reference Tarnow L, Gall MA, Hansen BV, et al: Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia. 2006, 49: 2256-62. 10.1007/s00125-006-0359-4.CrossRefPubMed Tarnow L, Gall MA, Hansen BV, et al: Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia. 2006, 49: 2256-62. 10.1007/s00125-006-0359-4.CrossRefPubMed
5.
go back to reference Abdullah SM, Khera A, Das SR, et al: Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol. 2005, 96 (9): 1284-9. 10.1016/j.amjcard.2005.06.073.CrossRefPubMed Abdullah SM, Khera A, Das SR, et al: Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study). Am J Cardiol. 2005, 96 (9): 1284-9. 10.1016/j.amjcard.2005.06.073.CrossRefPubMed
6.
go back to reference Poulsen MK, Henriksen JE, Dahl J, et al: Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients. J Nucl Cardiol. 2009, 16 (6): 878-87. 10.1007/s12350-009-9118-5.CrossRefPubMed Poulsen MK, Henriksen JE, Dahl J, et al: Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients. J Nucl Cardiol. 2009, 16 (6): 878-87. 10.1007/s12350-009-9118-5.CrossRefPubMed
7.
go back to reference Christensen LL, Anker-Nielsen A, Almdal TP: Development in Quality of Treatment in Complicated Type 2 Diabetes Assessed by the Proportion of Patients Reaching ADA Goals. Diab. 2010, 59: A180-A181. Christensen LL, Anker-Nielsen A, Almdal TP: Development in Quality of Treatment in Complicated Type 2 Diabetes Assessed by the Proportion of Patients Reaching ADA Goals. Diab. 2010, 59: A180-A181.
8.
go back to reference Reinhard H, Hansen PR, Persson F, et al: Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. Nephrol Dial Transplant. 2011 Reinhard H, Hansen PR, Persson F, et al: Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. Nephrol Dial Transplant. 2011
9.
go back to reference Agatston AS, Janowitz WR, Hildner FJ, et al: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990, 15 (4): 827-32. 10.1016/0735-1097(90)90282-T.CrossRefPubMed Agatston AS, Janowitz WR, Hildner FJ, et al: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990, 15 (4): 827-32. 10.1016/0735-1097(90)90282-T.CrossRefPubMed
10.
go back to reference Simons DB, Schwartz RS, Edwards WD, et al: Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol. 1992, 20 (5): 1118-26. 10.1016/0735-1097(92)90367-V.CrossRefPubMed Simons DB, Schwartz RS, Edwards WD, et al: Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study. J Am Coll Cardiol. 1992, 20 (5): 1118-26. 10.1016/0735-1097(92)90367-V.CrossRefPubMed
11.
go back to reference Rumberger JA, Simons DB, Fitzpatrick LA, et al: Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995, 92 (8): 2157-62.CrossRefPubMed Rumberger JA, Simons DB, Fitzpatrick LA, et al: Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995, 92 (8): 2157-62.CrossRefPubMed
12.
go back to reference Oudkerk M, Stillman AE, Halliburton SS, et al: Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging. 2008, 24 (6): 645-71. 10.1007/s10554-008-9319-z.PubMedCentralCrossRefPubMed Oudkerk M, Stillman AE, Halliburton SS, et al: Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging. 2008, 24 (6): 645-71. 10.1007/s10554-008-9319-z.PubMedCentralCrossRefPubMed
13.
go back to reference Chiu YW, Adler SG, Budoff MJ, et al: Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int. 2010, 77 (12): 1107-14. 10.1038/ki.2010.70.CrossRefPubMed Chiu YW, Adler SG, Budoff MJ, et al: Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int. 2010, 77 (12): 1107-14. 10.1038/ki.2010.70.CrossRefPubMed
14.
go back to reference Laurent S, Cockcroft J, Van BL, et al: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006, 27 (21): 2588-605. 10.1093/eurheartj/ehl254.CrossRefPubMed Laurent S, Cockcroft J, Van BL, et al: Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006, 27 (21): 2588-605. 10.1093/eurheartj/ehl254.CrossRefPubMed
15.
go back to reference Lassen NA, Tvedegaard E, Jeppesen FI, et al: Distal blood pressure measurement in occlusive arterial disease, strain gauge compared to xenon-133. Angiology. 1972, 23 (4): 211-7. 10.1177/000331977202300405.CrossRefPubMed Lassen NA, Tvedegaard E, Jeppesen FI, et al: Distal blood pressure measurement in occlusive arterial disease, strain gauge compared to xenon-133. Angiology. 1972, 23 (4): 211-7. 10.1177/000331977202300405.CrossRefPubMed
16.
go back to reference Carter SA, Lezack JD: Digital systolic pressures in the lower limb in arterial disease. Circulation. 1971, 43: 905-14.CrossRefPubMed Carter SA, Lezack JD: Digital systolic pressures in the lower limb in arterial disease. Circulation. 1971, 43: 905-14.CrossRefPubMed
17.
go back to reference Hamburg NM, Keyes MJ, Larson MG, et al: Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008, 117 (19): 2467-74. 10.1161/CIRCULATIONAHA.107.748574.PubMedCentralCrossRefPubMed Hamburg NM, Keyes MJ, Larson MG, et al: Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008, 117 (19): 2467-74. 10.1161/CIRCULATIONAHA.107.748574.PubMedCentralCrossRefPubMed
18.
go back to reference Bonetti PO, Pumper GM, Higano ST, et al: Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. Journal of the American College of Cardiology. 2004, 44 (11): 2137-41. 10.1016/j.jacc.2004.08.062.CrossRefPubMed Bonetti PO, Pumper GM, Higano ST, et al: Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. Journal of the American College of Cardiology. 2004, 44 (11): 2137-41. 10.1016/j.jacc.2004.08.062.CrossRefPubMed
19.
go back to reference Higashi Y, Sasaki S, Nakagawa K, et al: A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol. 2001, 87 (1): 121-5. 10.1016/S0002-9149(00)01288-1. A9.CrossRefPubMed Higashi Y, Sasaki S, Nakagawa K, et al: A noninvasive measurement of reactive hyperemia that can be used to assess resistance artery endothelial function in humans. Am J Cardiol. 2001, 87 (1): 121-5. 10.1016/S0002-9149(00)01288-1. A9.CrossRefPubMed
20.
go back to reference Hamilton PK, Lockhart CJ, Quinn CE, et al: Arterial stiffness: clinical relevance, measurement and treatment. Clin Sci (Lond). 2007, 113 (4): 157-70. 10.1042/CS20070080.CrossRef Hamilton PK, Lockhart CJ, Quinn CE, et al: Arterial stiffness: clinical relevance, measurement and treatment. Clin Sci (Lond). 2007, 113 (4): 157-70. 10.1042/CS20070080.CrossRef
21.
go back to reference Heffernan KS, Patvardhan EA, Hession M, et al: Elevated augmentation index derived from peripheral arterial tonometry is associated with abnormal ventricular-vascular coupling. Clin Physiol Funct Imaging. 2010, 30 (5): 313-7.PubMedCentralPubMed Heffernan KS, Patvardhan EA, Hession M, et al: Elevated augmentation index derived from peripheral arterial tonometry is associated with abnormal ventricular-vascular coupling. Clin Physiol Funct Imaging. 2010, 30 (5): 313-7.PubMedCentralPubMed
22.
go back to reference Reinhard H, Hansen PR, Persson F, et al: Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. Nephrol Dial Transplant. 2011 Reinhard H, Hansen PR, Persson F, et al: Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate. Nephrol Dial Transplant. 2011
23.
go back to reference Gaede P, Hildebrandt P, Hess G, et al: Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia. 2005, 48 (1): 156-63. 10.1007/s00125-004-1607-0.CrossRefPubMed Gaede P, Hildebrandt P, Hess G, et al: Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria. Diabetologia. 2005, 48 (1): 156-63. 10.1007/s00125-004-1607-0.CrossRefPubMed
24.
go back to reference Magnusson M, Jovinge S, Shahgaldi K, et al: Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients. Cardiovasc Diabetol. 2010, 9: 2-10.1186/1475-2840-9-2.PubMedCentralCrossRefPubMed Magnusson M, Jovinge S, Shahgaldi K, et al: Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients. Cardiovasc Diabetol. 2010, 9: 2-10.1186/1475-2840-9-2.PubMedCentralCrossRefPubMed
25.
go back to reference Romano S, Di MM, Fratini S, et al: Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides. Cardiovasc Diabetol. 2010, 9: 89-10.1186/1475-2840-9-89.PubMedCentralCrossRefPubMed Romano S, Di MM, Fratini S, et al: Early diagnosis of left ventricular diastolic dysfunction in diabetic patients: a possible role for natriuretic peptides. Cardiovasc Diabetol. 2010, 9: 89-10.1186/1475-2840-9-89.PubMedCentralCrossRefPubMed
26.
go back to reference Mangge H, Almer G, Zelzer S, et al: N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity. Clin Chem Lab Med. 2011 Mangge H, Almer G, Zelzer S, et al: N-terminal pro-B-type natriuretic peptide in early and advanced phases of obesity. Clin Chem Lab Med. 2011
27.
go back to reference Novo G, Corrado E, Tortorici E, et al: Cardiac risk stratification in elective non-cardiac surgery: role of NT-proBNP. Int Angiol. 2011, 30 (3): 242-6.PubMed Novo G, Corrado E, Tortorici E, et al: Cardiac risk stratification in elective non-cardiac surgery: role of NT-proBNP. Int Angiol. 2011, 30 (3): 242-6.PubMed
28.
go back to reference Macheret F, Boerrigter G, McKie P, et al: Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction. J Am Coll Cardiol. 2011, 57 (12): 1386-95. 10.1016/j.jacc.2011.01.005.PubMedCentralCrossRefPubMed Macheret F, Boerrigter G, McKie P, et al: Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction. J Am Coll Cardiol. 2011, 57 (12): 1386-95. 10.1016/j.jacc.2011.01.005.PubMedCentralCrossRefPubMed
29.
go back to reference Crouse JR, Raichlen JS, Riley WA, et al: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007, 297 (12): 1344-53. 10.1001/jama.297.12.1344.CrossRefPubMed Crouse JR, Raichlen JS, Riley WA, et al: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA. 2007, 297 (12): 1344-53. 10.1001/jama.297.12.1344.CrossRefPubMed
30.
go back to reference Kang S, Wu Y, Li X: Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis. 2004, 177 (2): 433-42. 10.1016/j.atherosclerosis.2004.08.005.CrossRefPubMed Kang S, Wu Y, Li X: Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis. 2004, 177 (2): 433-42. 10.1016/j.atherosclerosis.2004.08.005.CrossRefPubMed
31.
go back to reference Touboul PJ, Labreuche J, Vicaut E, et al: Country-based reference values and impact of cardiovascular risk factors on carotid intima-media thickness in a French population: the 'Paroi Arterielle et Risque Cardio-Vasculaire' (PARC) Study. Cerebrovasc Dis. 2009, 27 (4): 361-7. 10.1159/000202013.CrossRefPubMed Touboul PJ, Labreuche J, Vicaut E, et al: Country-based reference values and impact of cardiovascular risk factors on carotid intima-media thickness in a French population: the 'Paroi Arterielle et Risque Cardio-Vasculaire' (PARC) Study. Cerebrovasc Dis. 2009, 27 (4): 361-7. 10.1159/000202013.CrossRefPubMed
32.
go back to reference Scholte AJ, Schuijf JD, Kharagjitsingh AV, et al: Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008, 94 (3): 290-5. 10.1136/hrt.2007.121921.CrossRefPubMed Scholte AJ, Schuijf JD, Kharagjitsingh AV, et al: Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008, 94 (3): 290-5. 10.1136/hrt.2007.121921.CrossRefPubMed
33.
go back to reference Faglia E, Caravaggi C, Marchetti R, et al: Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed Type 2 diabetic patients. Diabet Med. 2005, 22 (10): 1310-4. 10.1111/j.1464-5491.2005.01612.x.CrossRefPubMed Faglia E, Caravaggi C, Marchetti R, et al: Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed Type 2 diabetic patients. Diabet Med. 2005, 22 (10): 1310-4. 10.1111/j.1464-5491.2005.01612.x.CrossRefPubMed
34.
go back to reference Norgren L, Hiatt WR, Dormandy JA, et al: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007, 33 (Suppl 1): S1-75.CrossRefPubMed Norgren L, Hiatt WR, Dormandy JA, et al: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007, 33 (Suppl 1): S1-75.CrossRefPubMed
35.
go back to reference Dalager S, Paaske WP, Kristensen IB, et al: Artery-related differences in atherosclerosis expression: implications for atherogenesis and dynamics in intima-media thickness. Stroke. 2007, 38 (10): 2698-705. 10.1161/STROKEAHA.107.486480.CrossRefPubMed Dalager S, Paaske WP, Kristensen IB, et al: Artery-related differences in atherosclerosis expression: implications for atherogenesis and dynamics in intima-media thickness. Stroke. 2007, 38 (10): 2698-705. 10.1161/STROKEAHA.107.486480.CrossRefPubMed
36.
go back to reference Dalager S, Falk E, Kristensen IB, et al: Plaque in superficial femoral arteries indicates generalized atherosclerosis and vulnerability to coronary death: an autopsy study. J Vasc Surg. 2008, 47 (2): 296-302. 10.1016/j.jvs.2007.10.037.CrossRefPubMed Dalager S, Falk E, Kristensen IB, et al: Plaque in superficial femoral arteries indicates generalized atherosclerosis and vulnerability to coronary death: an autopsy study. J Vasc Surg. 2008, 47 (2): 296-302. 10.1016/j.jvs.2007.10.037.CrossRefPubMed
37.
go back to reference Ninomiya T, Perkovic V, de Galan BE, et al: Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009, 20 (8): 1813-21. 10.1681/ASN.2008121270.PubMedCentralCrossRefPubMed Ninomiya T, Perkovic V, de Galan BE, et al: Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009, 20 (8): 1813-21. 10.1681/ASN.2008121270.PubMedCentralCrossRefPubMed
38.
go back to reference Raggi P, Shaw LJ, Berman DS, et al: Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004, 43 (9): 1663-9. 10.1016/j.jacc.2003.09.068.CrossRefPubMed Raggi P, Shaw LJ, Berman DS, et al: Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004, 43 (9): 1663-9. 10.1016/j.jacc.2003.09.068.CrossRefPubMed
39.
go back to reference Bernard S, Serusclat A, Targe F, et al: Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005, 28 (5): 1158-62. 10.2337/diacare.28.5.1158.CrossRefPubMed Bernard S, Serusclat A, Targe F, et al: Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005, 28 (5): 1158-62. 10.2337/diacare.28.5.1158.CrossRefPubMed
40.
go back to reference Norman PE, Davis WA, Bruce DG, et al: Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2006, 29 (3): 575-80. 10.2337/diacare.29.03.06.dc05-1567.CrossRefPubMed Norman PE, Davis WA, Bruce DG, et al: Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2006, 29 (3): 575-80. 10.2337/diacare.29.03.06.dc05-1567.CrossRefPubMed
Metadata
Title
NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
Authors
Henrik Reinhard
Niels Wiinberg
Peter R Hansen
Andreas Kjær
Claus L Petersen
Kaj Winther
Hans-Henrik Parving
Peter Rossing
Peter K Jacobsen
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2011
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-10-71

Other articles of this Issue 1/2011

Cardiovascular Diabetology 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.